These studies suggest that lumican is involved in the bone metastasis of lung cancer cells by modulating bone remodeling, increasing the mobility, and serving as a chemoattractant for lung cancer cells, thereby promoting cell invasion. The gene discussed is LUM; the disease is lung carcinoma.